Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00041067
Status:
COMPLETED
Last Update Posted:
2013-06-06
First Post:
2002-07-08
Brief Title:
S0215 Trastuzumab Docetaxel Vinorelbine and Filgrastim in Treating Women With Stage IV Breast Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
SWOG Cancer Research Network
Organization Data
Organization:
SWOG Cancer Research Network
Class:
NETWORK
Study ID:
CDR0000069440
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SWOG Cancer Research Network
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |